Robert Kramer, President and CEO at Emergent BioSolutions Inc. (EBS), sold 77,794 shares at $120.03 ($9.3M) on 2021-02-08, disclosed to the SEC on 2021-02-09.
Open-market sale of $9.3M EBS by President and CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $120.03 | 13,000 | $1.6M | 16.7% |
| 2 | $120.03 | 32,397 | $3.9M | 41.6% |
| 3 | $120.03 | 32,397 | $3.9M | 41.6% |
| Total | $120.03 avg | 77,794 | $9.3M | 100% |
| Filing → |
| EBS | SELL | 2016-04-08 | $847K | — | Filing → |
| EBS | SELL | 2016-04-05 | $804K | — | Filing → |
| EBS | SELL | 2016-04-05 | $3.0M | — | Filing → |